KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Retained Earnings: 2010-2024

Historic Retained Earnings for Pacira BioSciences (PCRX) over the last 15 years, with Dec 2024 value amounting to -$206.4 million.

  • Pacira BioSciences' Retained Earnings rose 9.64% to -$201.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$201.0 million, marking a year-over-year increase of 9.64%. This contributed to the annual value of -$206.4 million for FY2024, which is 93.22% down from last year.
  • Per Pacira BioSciences' latest filing, its Retained Earnings stood at -$206.4 million for FY2024, which was down 93.22% from -$106.8 million recorded in FY2023.
  • In the past 5 years, Pacira BioSciences' Retained Earnings registered a high of -$106.8 million during FY2023, and its lowest value of -$253.9 million during FY2020.
  • Over the past 3 years, Pacira BioSciences' median Retained Earnings value was -$148.8 million (recorded in 2022), while the average stood at -$154.0 million.
  • In the last 5 years, Pacira BioSciences' Retained Earnings spiked by 36.44% in 2020 and then tumbled by 93.22% in 2024.
  • Yearly analysis of 5 years shows Pacira BioSciences' Retained Earnings stood at -$253.9 million in 2020, then grew by 16.54% to -$211.9 million in 2021, then increased by 29.80% to -$148.8 million in 2022, then rose by 28.20% to -$106.8 million in 2023, then slumped by 93.22% to -$206.4 million in 2024.